The Oxford/AstraZeneca vaccine will be tested in a new trial after questions over its data
It’s hoping to assuage concerns over the way it collected and presented its data so far. By MIT Technology Review The news: The Oxford University/AstraZeneca vaccine will be tested in a new global trial, AstraZeneca’s CEO, Pascal Soriot...
READ MORE